Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Macrophage Activation as an Effector Mechanism for Cell-Mediated Immunity

Vincent C. Tam and Alan Aderem
J Immunol October 1, 2014, 193 (7) 3183-3184; DOI: https://doi.org/10.4049/jimmunol.1402046
Vincent C. Tam
Seattle Biomedical Research Institute, Seattle, WA 98109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Aderem
Seattle Biomedical Research Institute, Seattle, WA 98109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Myeloid cells function as major bridges between the innate and adaptive immune systems. First, dendritic cells orchestrate an appropriate adaptive immune response through Ag presentation, a landmark finding that garnered a Nobel Prize for Ralph Steinman (1). Less well known are the findings of George Mackaness from the John Curtin School of Medical Research in Australia, who demonstrated a second intersection between the innate and adaptive immune responses: that macrophages can serve as effector cells for acquired cell-mediated immunity. In 1962, his article titled “Cellular Resistance to Infection” was published in The Journal of Experimental Medicine (2), highlighted here along with a second seminal article by Mackaness from 1964 (3) as a Pillar of Immunology. At the time, Ab-dependent immune responses were well appreciated, but cellular immunity was not generally accepted. However, there were a number of lines of evidence that pointed to a major role for cellular immunity. For example, the humoral response alone did not correlate with protection in all infections, especially ones caused by intracellular pathogens (4).

Mackaness used Listeria monocytogenes, a facultative, intracellular pathogen, to investigate cellular resistance (2). His decision to use this pathogen was based on previous observations suggesting that the clearance of L. monocytogenes was not dependent on humoral immunity (5, 6). Because the parental strain of L. monocytogenes was unable to persist in mouse macrophages, Mackaness used serial passaging, a technique described in the original discovery of L. monocytogenes (7), to enhance its virulence. Interestingly, the bacterium increased in virulence regardless of whether it had been passaged in vivo or in cultured macrophages. This observation legitimized the in vitro infection model that was used in parallel with the mouse model. With L. monocytogenes as the pathogen and outbred mice as the host, Mackaness demonstrated acquired cellular immunity by primary infection and secondary challenge. Whereas naive animals were susceptible to Listeria infection, previously infected animals could withstand a secondary infection of 10 LD50 (2). This acquired resistance persisted for at least 13 wk after primary infection. The role of Abs in acquired resistance to Listeria was ruled out when serum from immunized animals failed to reduce bacterial growth in recipient animals. Mackaness also observed that the emergence of delayed-type hypersensitivity, now known as a surrogate for assessing cell-mediated immunity, coincided with the antibacterial response. Detailed histological studies of the spleen and liver identified mononuclear cells as the dominant population during secondary challenge. Macrophages isolated from previously infected animals were distinct morphologically and phenotypically from macrophages isolated from naive animals. These ex vivo macrophages from immunized animals were also resistant to Listeria infection in vitro. The data led him to conclude that macrophages from mice previously infected with intracellular pathogens were resistant to secondary challenge. In subsequent work also highlighted here, using L. monocytogenes, Brucella abortus, and Mycobacterium tuberculosis, Mackaness demonstrated that these activated macrophages have nonspecific resistance to unrelated pathogens, but only when cellular immunity has been established in vivo (3). This resistance was due to enhanced nonspecific bactericidal activities within the macrophage. Finally, he demonstrated that lymphocytes transferred from immunized animals altered the bactericidal activity of the recipient macrophages (8, 9). Thus, the interdependence of the innate and adaptive immune responses in successfully protecting the host against intracellular pathogens was revealed. Mackaness’ seminal work set the stage for the molecular characterization of macrophage activation, such as the 1983 publications by two groups, first-authored by Carl Nathan and Robert Schreiber, demonstrating that T cell–secreted IFN-γ was the factor that stimulated macrophages to increase their bactericidal activity during cellular immunity (10, 11). Mackaness’ work clearly demonstrated the involvement of macrophages in the complex interactions between cells that play key roles in innate and adaptive immunity, and it laid the foundation for current research focused on dissecting the mechanisms that drive this crosstalk.

Disclosures

The authors have no financial conflicts of interest.

  • Copyright © 2014 by The American Association of Immunologists, Inc.

References

  1. ↵
    1. Steinman R. M.,
    2. Z. A. Cohn
    . 1973. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137: 1142–1162.
    OpenUrlAbstract
  2. ↵
    1. Mackaness G. B.
    1962. Cellular resistance to infection. J. Exp. Med. 116: 381–406.
    OpenUrlAbstract
  3. ↵
    1. Mackaness G. B.
    1964. The immunological basis of acquired cellular resistance. J. Exp. Med. 120: 105–120.
    OpenUrlAbstract
  4. ↵
    1. Raffel S.
    1949. Types of acquired immunity against infectious disease. Annu. Rev. Microbiol. 3: 221–264.
    OpenUrlCrossRef
  5. ↵
    1. Osebold J. W.,
    2. M. T. Sawyer
    . 1957. Immunization studies on listeriosis in mice. J. Immunol. 78: 262–268.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Julianelle L. A.
    1941. Biological and immunological studies of Listerella. J. Bacteriol. 42: 367–383.
    OpenUrlFREE Full Text
  7. ↵
    1. Murray E. G. D.,
    2. R. A. Webb,
    3. M. B. R. Swan
    . 1926. A disease of rabbits characterised by a large mononuclear leucocytosis, caused by a hitherto undescribed bacillus Bacterium monocytogenes (n.sp.). J. Pathol. 29: 407–439.
    OpenUrlCrossRef
  8. ↵
    1. Mackaness G. B.
    1969. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J. Exp. Med. 129: 973–992.
    OpenUrlAbstract
  9. ↵
    1. Mackaness G. B.,
    2. W. C. Hill
    . 1969. The effect of anti-lymphocyte globulin on cell-mediated reistance to infection. J. Exp. Med. 129: 993–1012.
    OpenUrlAbstract
  10. ↵
    1. Nathan C. F.,
    2. H. W. Murray,
    3. M. E. Wiebe,
    4. B. Y. Rubin
    . 1983. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158: 670–689.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Schreiber R. D.,
    2. J. L. Pace,
    3. S. W. Russell,
    4. A. Altman,
    5. D. H. Katz
    . 1983. Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon. J. Immunol. 131: 826–832.
    OpenUrlAbstract
PreviousNext
Back to top

In this issue

The Journal of Immunology: 193 (7)
The Journal of Immunology
Vol. 193, Issue 7
1 Oct 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Macrophage Activation as an Effector Mechanism for Cell-Mediated Immunity
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Macrophage Activation as an Effector Mechanism for Cell-Mediated Immunity
Vincent C. Tam, Alan Aderem
The Journal of Immunology October 1, 2014, 193 (7) 3183-3184; DOI: 10.4049/jimmunol.1402046

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Macrophage Activation as an Effector Mechanism for Cell-Mediated Immunity
Vincent C. Tam, Alan Aderem
The Journal of Immunology October 1, 2014, 193 (7) 3183-3184; DOI: 10.4049/jimmunol.1402046
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Conceiving the Inconceivable: The Function of Aire in Immune Tolerance to Peripheral Tissue-Restricted Antigens in the Thymus
  • Glial Cells as Regulators of Neuroimmune Interactions in the Central Nervous System
  • The Colon as a Major Site of Immunoregulation by CD4+ T Cell Subsets in the Steady State
Show more PILLARS OF IMMUNOLOGY

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606